中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共6条，第1-6条

帮助

条数/页：排序方式：
	Identification of CDKN1A as a potential key risk factor in MASLD progression 期刊论文 OAI收割 FASEB JOURNAL, 2025, 卷号: 39, 期号: 7, 页码: 15 作者: Deng, Lijuan; Deng, Jianxin; Luo, Liping; Yang, Hongjia; Sun, Mengxue \| 收藏 \| 浏览/下载：1/0 \| 提交时间：2025/05/27 biomarkers CDKN1A liver MASLD RNA-seq
	Drug discovery targeting thyroid hormone receptor f3 (THRf3) for the treatment of liver diseases and other medical indications 期刊论文 OAI收割 ACTA PHARMACEUTICA SINICA B, 2025, 卷号: 15, 期号: 1, 页码: 35-51 作者: Wang, Kean; Chen, Feiyang; Wang, Jiang; Liu, Hong \| 收藏 \| 浏览/下载：14/0 \| 提交时间：2025/04/01 Thyroid hormone Thyroid hormone /3 receptor MASLD MASH THR/3 agonist
	MicroRNAs in metabolic dysfunction-associated diseases: Pathogenesis and therapeutic opportunities 期刊论文 OAI收割 FASEB JOURNAL, 2024, 卷号: 38, 期号: 17, 页码: 21 作者: Ma, Ningning; Tan, Jiaxin; Chen, Yingfen; Yang, Liu; Li, Man \| 收藏 \| 浏览/下载：20/0 \| 提交时间：2024/10/21 ALD diabetes MASLD MiRNAs obesity
	FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 15 作者: Wen, Ying-quan; Zou, Zi-yuan; Zhao, Guan-guan; Zhang, Meng-jiao; Zhang, Yong-xin \| 收藏 \| 浏览/下载：12/0 \| 提交时间：2024/08/22 MASLD/MASH FXR transcriptome gut-liver axis agonist
	New advances in drug development for metabolic dysfunction-associated diseases and alcohol-associated liver disease 期刊论文 OAI收割 CELL AND BIOSCIENCE, 2024, 卷号: 14, 期号: 1, 页码: 18 作者: Zhang, Jinming; Li, Yixin; Yang, Liu; Ma, Ningning; Qian, Shengying \| 收藏 \| 浏览/下载：8/0 \| 提交时间：2024/08/22 MASLD ALD T2DM Metabolic disorder Drug candidate
	Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets 期刊论文 OAI收割 SEMINARS IN LIVER DISEASE, 2024, 页码: 14 作者: Qian, Shengying; Wang, Xiaolin \| 收藏 \| 浏览/下载：18/0 \| 提交时间：2024/08/22 ALD MASLD macrophages neutrophils single-cell RNA sequencing